Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Mylan Laboratories Limited (N.D.W. Va. 2022)
✉ Email this page to a colleague
Otsuka Pharmaceutical Co., Ltd. v. Mylan Laboratories Limited (N.D.W. Va. 2022)
| Docket | ⤷ Try a Trial | Date Filed | 2022-11-10 |
| Court | District Court, N.D. West Virginia | Date Terminated | 2023-03-07 |
| Cause | 35:271 Patent Infringement | Assigned To | Thomas Shawn Kleeh |
| Jury Demand | None | Referred To | |
| Parties | MYLAN LABORATORIES LIMITED | ||
| Patents | 10,525,057; 7,807,680; 8,030,313; 8,338,427; 8,399,469; 8,722,679 | ||
| Attorneys | Brandon M. White | ||
| Firms | Perkins Coie LLP, District of Columbia | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Mylan Laboratories Limited
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Otsuka Pharmaceutical Co., Ltd. v. Mylan Laboratories Limited (N.D.W. Va. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-11-10 | 1 | Complaint (NOT for attorney use) | “the ’469 patent”), 8,338,427 (“the ’427 patent”), 10,525,057 (“the ’057 patent”), 10,980,803 (“the ’…action for patent infringement of U.S. Patent No. 11,400,087 (“the ’087 patent” or “the patent-in-suit”…,680 (“the ’680 patent”), 8,030,313 (“the ’313 patent”), 8,722,679 (“the ’679 patent”), 8,399,469 (“the… ’803 patent”) and 11,154,553 (“the ’553 patent”) (collectively, “First Suit Patents”), first in the …Defendants for patent infringement, which included counts for infringement of U.S. Patent Nos. 7,807,680 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
